Cargando…

Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners

In patients with heart failure (HF), iron deficiency (ID) correlates with decreased exercise capacity and poor health-related quality of life, and predicts worse outcomes. Both absolute (depleted iron stores) and functional (where iron is unavailable for dedicated tissues) ID can be easily evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drozd, Marcin, Jankowska, Ewa A., Banasiak, Waldemar, Ponikowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435776/ https://www.ncbi.nlm.nih.gov/pubmed/28039585 http://dx.doi.org/10.1007/s40256-016-0211-2

Ejemplares similares

Monitoring of iron status in patients with heart failure
por: Jankowska, Ewa A, et al.
Publicado: (2019)

Iron Deficiency in Heart Failure: A Korea-Oriented Review
por: Jankowska, Ewa A., et al.
Publicado: (2023)

Iron status, catabolic/anabolic balance, and skeletal muscle performance in men with heart failure with reduced ejection fraction
por: Tkaczyszyn, Michał, et al.
Publicado: (2021)

Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2018)

Iron Deficiency and Deranged Myocardial Energetics in Heart Failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2022)

Structural and functional abnormalities in iron-depleted heart
por: Kobak, Kamil A, et al.
Publicado: (2018)

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
por: Jankowska, Ewa A., et al.
Publicado: (2013)

Iron deficiency as energetic insult to skeletal muscle in chronic diseases
por: Dziegala, Magdalena, et al.
Publicado: (2018)

Iron limitation promotes the atrophy of skeletal myocytes, whereas iron supplementation prevents this process in the hypoxic conditions
por: Kobak, Kamil, et al.
Publicado: (2018)

Iron deficiency as an emerging therapeutic target in patients stabilized after an episode of acute heart failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2021)

Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients
por: Martin‐Malo, Alejandro, et al.
Publicado: (2019)

Drug therapy in elderly heart failure patients
por: Jankowska, Ewa A, et al.
Publicado: (2019)

Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
por: Tkaczyszyn, Michał, et al.
Publicado: (2023)

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency(†)
por: Ponikowski, Piotr, et al.
Publicado: (2015)

Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones
por: Josiak, Krystian, et al.
Publicado: (2014)

Iron deficiency in heart failure
por: Loncar, Goran, et al.
Publicado: (2021)

Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising AFFIRM‐AHF
por: McEwan, Phil, et al.
Publicado: (2021)

Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
por: McDonagh, Theresa, et al.
Publicado: (2015)

Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency
por: Butler, Javed, et al.
Publicado: (2022)

Iron Depletion Affects Genes Encoding Mitochondrial Electron Transport Chain and Genes of NonOxidative Metabolism, Pyruvate Kinase and Lactate Dehydrogenase, in Primary Human Cardiac Myocytes Cultured upon Mechanical Stretch
por: Dziegala, Magdalena, et al.
Publicado: (2018)

The role of iron deficiency in heart failure
por: Caminiti, Giuseppe, et al.
Publicado: (2023)

Treatment of Iron Deficiency in Heart Failure
por: Shamsi, Aamir, et al.
Publicado: (2023)

Iron deficiency and cardiovascular disease
por: Savarese, Gianluigi, et al.
Publicado: (2022)

Health locus of control and the sense of self-efficacy in patients with systolic heart failure: a pilot study
por: Rydlewska, Agnieszka, et al.
Publicado: (2013)

Intravenous Iron Technique Evaluation in Chronic Heart Failure With Iron Deficiency Anemia
por: Gosavi, Rohit, et al.
Publicado: (2023)

Iron Deficiency in Acute Decompensated Heart Failure
por: Beale, Anna, et al.
Publicado: (2019)

Iron Deficiency in Heart Failure: Characteristics and Treatment
por: Martin, Ryan C, et al.
Publicado: (2021)

Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
por: Alnuwaysir, Ridha I. S., et al.
Publicado: (2021)

Iron Deficiency in Patients with Advanced Heart Failure
por: Bakosova, Maria, et al.
Publicado: (2022)

Iron Deficiency in Korean Patients With Heart Failure
por: Park, Jin Joo, et al.
Publicado: (2023)

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
por: van Veldhuisen, Dirk J., et al.
Publicado: (2017)

Improving the Outcome of Patients With Heart Failure: Assessment of Iron Deficiency and Intravenous Iron Replacement
por: Yera, Hassan O, et al.
Publicado: (2023)

Effect of iron supplementation in patients with heart failure and iron deficiency: A systematic review and meta-analysis
por: Yamani, Naser, et al.
Publicado: (2021)

Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis
por: Filippatos, Gerasimos, et al.
Publicado: (2023)

Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF
por: Docherty, Kieran F., et al.
Publicado: (2022)

Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany
por: Theidel, Ulrike, et al.
Publicado: (2017)

Iron therapy in iron-deficiency patients with heart failure with preserved ejection fraction: A protocol for meta-analysis
por: Fukuta, Hidekatsu, et al.
Publicado: (2021)

Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency
por: Anker, Stefan D., et al.
Publicado: (2022)

Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial
por: Metra, Marco, et al.
Publicado: (2022)

Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials
por: Graham, Fraser J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qo61bi9isvjd5gb8fnb14npdk9